Novel Drug Delivery Systems Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL NOVEL DRUG DELIVERY SYSTEMS INDUSTRY

2.1 Summary about Novel Drug Delivery Systems Industry

2.2 Novel Drug Delivery Systems Market Trends

2.2.1 Novel Drug Delivery Systems Production & Consumption Trends

2.2.2 Novel Drug Delivery Systems Demand Structure Trends

2.3 Novel Drug Delivery Systems Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Liposomes

4.2.2 PEGylated Proteins & Polypeptides

4.2.3 Polymer Nanoparticle

4.2.4 Protein–drug Conjugates

4.2.5 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Hospitals & Clinic

4.3.2 Cancer Treatment Centers

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Liposomes

5.2.2 PEGylated Proteins & Polypeptides

5.2.3 Polymer Nanoparticle

5.2.4 Protein–drug Conjugates

5.2.5 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Hospitals & Clinic

5.3.2 Cancer Treatment Centers

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Liposomes

6.2.2 PEGylated Proteins & Polypeptides

6.2.3 Polymer Nanoparticle

6.2.4 Protein–drug Conjugates

6.2.5 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Hospitals & Clinic

6.3.2 Cancer Treatment Centers

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Liposomes

7.2.2 PEGylated Proteins & Polypeptides

7.2.3 Polymer Nanoparticle

7.2.4 Protein–drug Conjugates

7.2.5 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Hospitals & Clinic

7.3.2 Cancer Treatment Centers

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Liposomes

8.2.2 PEGylated Proteins & Polypeptides

8.2.3 Polymer Nanoparticle

8.2.4 Protein–drug Conjugates

8.2.5 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Hospitals & Clinic

8.3.2 Cancer Treatment Centers

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Liposomes

9.2.2 PEGylated Proteins & Polypeptides

9.2.3 Polymer Nanoparticle

9.2.4 Protein–drug Conjugates

9.2.5 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Hospitals & Clinic

9.3.2 Cancer Treatment Centers

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Amgen

10.1.2 Teva

10.1.3 Union Chimique Belge (UCB)

10.1.4 Roche

10.1.5 Celgene

10.1.6 Sanofi

10.1.7 Merck

10.1.8 Johnson & Johnson

10.1.9 Takeda

10.1.10 Gilead Sciences

10.1.11 Pfizer

10.1.12 Dr Reddy

10.1.13 Samyang Biopharmaceuticals

10.1.14 TOLMAR

10.1.15 Astellas

10.1.16 AMAG Pharmaceuticals

10.1.17 AstraZeneca

10.1.18 AbbVie

10.1.19 Bausch＆Lomb

10.1.20 TWi Pharmaceuticals

10.1.21 Novartis

10.1.22 Aspen

10.1.23 Shire

10.1.24 Breckenridge Pharmaceuticals

10.1.25 Galen

10.2 Novel Drug Delivery Systems Sales Date of Major Players (2017-2020e)

10.2.1 Amgen

10.2.2 Teva

10.2.3 Union Chimique Belge (UCB)

10.2.4 Roche

10.2.5 Celgene

10.2.6 Sanofi

10.2.7 Merck

10.2.8 Johnson & Johnson

10.2.9 Takeda

10.2.10 Gilead Sciences

10.2.11 Pfizer

10.2.12 Dr Reddy

10.2.13 Samyang Biopharmaceuticals

10.2.14 TOLMAR

10.2.15 Astellas

10.2.16 AMAG Pharmaceuticals

10.2.17 AstraZeneca

10.2.18 AbbVie

10.2.19 Bausch＆Lomb

10.2.20 TWi Pharmaceuticals

10.2.21 Novartis

10.2.22 Aspen

10.2.23 Shire

10.2.24 Breckenridge Pharmaceuticals

10.2.25 Galen

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Novel Drug Delivery Systems Product Type Overview

Table Novel Drug Delivery Systems Product Type Market Share List

Table Novel Drug Delivery Systems Product Type of Major Players

Table Brief Introduction of Amgen

Table Brief Introduction of Teva

Table Brief Introduction of Union Chimique Belge (UCB)

Table Brief Introduction of Roche

Table Brief Introduction of Celgene

Table Brief Introduction of Sanofi

Table Brief Introduction of Merck

Table Brief Introduction of Johnson & Johnson

Table Brief Introduction of Takeda

Table Brief Introduction of Gilead Sciences

Table Brief Introduction of Pfizer

Table Brief Introduction of Dr Reddy

Table Brief Introduction of Samyang Biopharmaceuticals

Table Brief Introduction of TOLMAR

Table Brief Introduction of Astellas

Table Brief Introduction of AMAG Pharmaceuticals

Table Brief Introduction of AstraZeneca

Table Brief Introduction of AbbVie

Table Brief Introduction of Bausch＆Lomb

Table Brief Introduction of TWi Pharmaceuticals

Table Brief Introduction of Novartis

Table Brief Introduction of Aspen

Table Brief Introduction of Shire

Table Brief Introduction of Breckenridge Pharmaceuticals

Table Brief Introduction of Galen

Table Products & Services of Amgen

Table Products & Services of Teva

Table Products & Services of Union Chimique Belge (UCB)

Table Products & Services of Roche

Table Products & Services of Celgene

Table Products & Services of Sanofi

Table Products & Services of Merck

Table Products & Services of Johnson & Johnson

Table Products & Services of Takeda

Table Products & Services of Gilead Sciences

Table Products & Services of Pfizer

Table Products & Services of Dr Reddy

Table Products & Services of Samyang Biopharmaceuticals

Table Products & Services of TOLMAR

Table Products & Services of Astellas

Table Products & Services of AMAG Pharmaceuticals

Table Products & Services of AstraZeneca

Table Products & Services of AbbVie

Table Products & Services of Bausch＆Lomb

Table Products & Services of TWi Pharmaceuticals

Table Products & Services of Novartis

Table Products & Services of Aspen

Table Products & Services of Shire

Table Products & Services of Breckenridge Pharmaceuticals

Table Products & Services of Galen

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Novel Drug Delivery Systems Market Forecast (Million USD) by Region 2021f-2026f

Table Global Novel Drug Delivery Systems Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Novel Drug Delivery Systems Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Novel Drug Delivery Systems Market Forecast (Million USD) Share by Demand 2021f-2026f